Fig. 2. Fas-L treatment leads to an increase in CD105-low and CD73-high subpopulations of cultured SVF cells at passages 0 and 1.

P0 (a) and P1 ASCs (b), cultured under normal culture conditions or with 50 ng/ml Fas-L, were examined for their surface marker expression of CD45, CD31, CD34, CD29, CD105, and CD73 by flow cytometry. The experiment was repeated two times using cells from two independent patients giving the same trend